The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for JK von Frijtag Drabbe Künzel


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.EBI
Leiden/Amsterdam Center For Drug Research
A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.EBI
Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport proteins by C8-alkylamine-substituted purines.EBI
Leiden University
New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.EBI
University of Leiden
N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.EBI
Leiden University
5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors.EBI
Leiden University
5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.EBI
Leiden/Amsterdam Center For Drug Research
N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.EBI
University of Ghent
Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.EBI
Leiden University
2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes.EBI
University of Amsterdam
Interference of linoleic acid fraction in some receptor binding assays.EBI
Leiden University
2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists.EBI
Leiden/Amsterdam Center For Drug Research
Inhibition of nucleoside transport by new analogues of 4-nitrobenzylthioinosine: replacement of the ribose moiety by substituted benzyl groups.EBI
Leiden University
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.EBI
National Institute of Diabetes